http://biz.yahoo.com/ic/news/515.htmlThe latest news on the Biotechnology industry from Yahoo! Financeen-usFri, 3 Jul 2009 16:00:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090703/20090703005040.html?.v=1LOS ANGELES----Cougar Biotechnology, Inc. announced today that the initial offering period of Johnson & Johnson's tender offer for all the outstanding shares of Cougar common stock expired at midnight on July 2, 2009.yahoo_finance/1255208156Fri, 3 Jul 2009 16:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/090703/ny41910.html?.v=1yahoo_finance/512449834Fri, 3 Jul 2009 12:53:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ibd/090702/health.html?.v=1Excitement over its Provenge cancer drug continues to build at Dendreon, the Seattle-based biotech that has seen shares hover near their all-time...yahoo_finance/2296629475Thu, 2 Jul 2009 22:14:03 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090702/us_genentech_lucentis_trial.html?.v=3Genentech Inc. said Thursday its macular degeneration drug Lucentis met its goal in a late stage trial, improving the vision of patients with macular edema due to branch retinal vein occlusion.yahoo_finance/1488388178Thu, 2 Jul 2009 20:01:53 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090702/20090702005585.html?.v=1CAMBRIDGE, Mass.----Biogen Idec Inc. today announced it will report second quarter 2009 financial results on Thursday, July 16, 2009, before the financial markets open.yahoo_finance/2367846162Thu, 2 Jul 2009 20:01:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12v5df5td/*http%3A//www.thestreet.com/_yahoo/story/10533965/1/four-must-see-charts-stem-cell-stocks.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/2691656636Thu, 2 Jul 2009 19:23:39 Etc/GMThttp://us.rd.yahoo.com/finance/external/hftn/rss/SIG=12tkc03qs/*http%3A//money.cnn.com/2009/07/02/technology/illumina_gene_dna_sequencing.fortune/index.htm?source=yahoo_quoteBiotech firm Illumina will sequence your entire genetic code -- and throw in a Mac -- for $48,000.yahoo_finance/3318624447Thu, 2 Jul 2009 19:16:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=126of5tnj/*http%3A//seekingalpha.com/article/146779-is-ibb-the-best-biotech-etf?source=yahooyahoo_finance/3664151412Thu, 2 Jul 2009 18:49:08 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12kur0rse/*http%3A//philadelphia.bizjournals.com/philadelphia/stories/2009/06/29/daily46.html?ana=yfcpcyahoo_finance/172740429Thu, 2 Jul 2009 16:05:21 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090702/us_illumina_mover.html?.v=1Shares of Illumina Inc. sank Thursday after the genetic analysis instrument maker said revenue in the second quarter fell short of its own forecast and Wall Street estimates.yahoo_finance/2730019381Thu, 2 Jul 2009 16:00:37 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090702/us_discovery_laboratories_mover.html?.v=1Shares of Discovery Laboratories Inc. fell to their lowest point in a decade Thursday after the company said a Food and Drug Administration review standard places the approval of Surfaxin in doubt.yahoo_finance/1847460292Thu, 2 Jul 2009 15:43:38 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12g8ru2kq/*http%3A//louisville.bizjournals.com/louisville/stories/2009/06/29/daily39.html?ana=yfcpcyahoo_finance/3077488293Thu, 2 Jul 2009 15:06:33 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13856unmt/*http%3A//www.thestreet.com/_yahoo/story/10533340/1/biotech-stock-mailbag-spectrum-pharmaceuticals.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/97715426Thu, 2 Jul 2009 13:42:20 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12o4oq8d7/*http%3A//www.thestreet.com/_yahoo/story/10533340/1/biotech-stock-mailbag-spectrum.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/3185426735Thu, 2 Jul 2009 13:42:20 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090702/0515869.html?.v=1yahoo_finance/3650503996Thu, 2 Jul 2009 12:49:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/090702/la41121.html?.v=1Peregrine Pharmaceuticals, Inc. today announced that it will release its fourth quarter and fiscal year 2009 financial results on July 14, 2009 at 7:00 a.m. EDT and will host a conference call and webcast to discuss the results at 11:30 a.m.yahoo_finance/494034973Thu, 2 Jul 2009 11:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090702/20090702005067.html?.v=1CARLSBAD, Calif.----Life Technologies Corporation announced today it will report its second quarter 2009 financial results on Tuesday, July 28, 2009, after market close. The company will also hold a conference call on the same day at 4:30 p.m.yahoo_finance/4109893003Thu, 2 Jul 2009 11:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090702/20090702005085.html?.v=1SAN DIEGO----Illumina, Inc. today launched GoldenGate Indexing, a high-throughput genotyping solution that utilizes multi-sample indexing technology. Researchers may now screen up to 16 times as many samples per reaction as the standard GoldenGate Assay, increasing throughput from 288 samples per day to greater than 2000, while decreasing total reagent consumption.yahoo_finance/2761084931Thu, 2 Jul 2009 10:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090701/0515809.html?.v=1yahoo_finance/1180800905Thu, 2 Jul 2009 00:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090701/us_discovery_laboratories_fda.html?.v=2Discovery Laboratories Inc. said Wednesday the Food and Drug Administration will apply a new standard to the company's respiratory drug candidate application, likely further holding up approval.yahoo_finance/2618455476Wed, 1 Jul 2009 21:55:19 Etc/GMT